Biosynth brochures

Staad, 6 November 2024– Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date.

A must have primer for chemists, biochemists, and those working in across life sciences in industry and academia.

Sustainability is “meeting the needs of the present without compromising the ability of future generations to meet their own needs.”  

This white paper explores the growing significance of GalNAc clusters, highlighting their unique properties and potential applications.

Staad, 4 March 2025 - Biosynth are pleased to announce the appointment of Marie Leblanc to the role of Executive Vice President of Life Sciences.

A scientific guide to select the optimal enzyme substrate, providing information on their scientific background.

The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply.

This toolbox will guide you through the complexities of these important carbohydrates in some detail including sources, properties, and applications.

Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals. Expansion of capacity for reliable, sustainable, and flexible manufacturing solutions at any production scale.

The e-book describes sources of oligosaccharides, methods of isolation and recovery of oligosaccharides and analytical methods for oligosaccharides.

An introduction to the structure, history, chemistry, and some of their important applications in the life and medical sciences of nucleosides and nucleotides.

We follow the history of the isolation and characterisation of nucleic acids through to recognising their fundamental role as carriers of genetic information.

This miniguide offers an overview of bile acids, biosynthetic pathways, essential functions, and emerging applications.

A scientific guide to select the optimal enzyme substrate, providinginformation on their scientific background.

This webinar explores the urgent threat of emerging infectious diseases and how the world is preparing to fight back. Discover how Biosynth's vital reagents and custom manufacturing capabilities empower researchers and diagnostic companies to develop rapid, accurate tests for early detection and containment of outbreaks. Learn about the latest advancements in the field and gain insights into strategies for future pandemic preparedness.

Discover how our unique CLIPS tricyclic peptide chemistry ensures single-isomer selection early in the screening process, combined with a high-diversity screening method. We showcase the discovery and optimization of tricyclic peptides against high-value targets, like membrane receptor proteins and monoclonal antibodies. Whether you’re in research, biotech, or pharmaceuticals, learn how high-diversity tricyclic peptide screening can support your drug development projects.

As sustainability becomes a global mandate, life sciences companies face increasing pressure to replace traditional, resource-heavy processes with sustainable alternatives. This webinar, delivered by Biosynth experts, lays out clear answers to mastering green chemistry, a shift that’s transforming industry standards and creating significant market advantages.

This webinar delivers immediate, actionable insights on how to future-proof your organization and outperform competitors by implementing green chemistry practices.

Life science professionals seeking to advance peptide therapeutics will enjoy Biosynth's recent webinar on peptide drug discovery. The webinar recording delves into the challenges faced by researchers and presents Biosynth's innovative CLIPSTM technology as a potential solution.

From practical to pioneering, Biosynth’s integrated solutions across modalities help unlock new opportunities and overcome complex challenges for therapeutics, vaccines, and diagnostics projects of any scale.

Partner with us for products & expertise for your next breakthrough, supporting you from R&D to GMP with a portfolio of products and expert discovery and manufacturing services. From bioprocessing reagents and critical raw materials to custom chemistry or peptide projects and bioconjugates. Reduce the complexity your supply chain, consolidate your support with Biosynth.

Expertise and Experience

We have been helping our customers innovate for over 55 years by taking on the most complex challenges in organic chemical synthesis and producing custom molecules for novel products and projects. Biosynth works in partnership to deliver high quality materials and methods to take you and your organization forward. As part of our suite of end-to-end CDMO services, we offer custom synthesis as a stand-alone project or as part of a longer program towards large-scale or GMP manufacture.

Large Scale Manufacturing

Increasing scale with quality and flexibility. Our team of highly experienced chemists, technicians and project managers deliver products for pharmaceutical, diagnostic, analytical and research purposes.

We regularly manufacture a wide range of chemical entities, being experts in carbohydrates, nucleosides, and working with controlled substances, dyes and other materials.